Home
NewsNewsUNC Fertility has announced its plans for Collaboration with IVI RMA North America to bring best clinical and operational best practices across the region, expanding access to cutting-edge fertility treatments and research.
One of North Carolina’s leading providers when it comes to fertility treatment and care, UNC Fertility, on February 11, 2026, went ahead and announced its plans to expand to accommodate the growing demand from the growing population of the state and form a new collaboration with IVI RMA North America, which is one of the leading providers in terms of reproductive medicine services in the country.
The Raleigh location of the clinic has gone on to hire many new providers and is also looking to accommodate plans to open some more locations all across the state in a matter of time. The collaboration with IVI RMA North America will bring clinical and operational best practices for patient service in the Triangle and the surrounding region. IVI RMA Global, which is the parent company, goes on to offer reproductive medicine services in 15 countries with over 200 locations.
UNC Health’s Division Chief of Reproductive Endocrinology and Infertility and Medical Director at UNC Fertility, Dr. Colleen Milroy, said that “UNC Fertility is proud to serve the more than 2.4 million residents of the Triangle. Our region is one of the fastest growing in the country, and its population deserves the best patient care. This partnership with IVI RMA will ensure UNC Fertility is well-positioned to scale access over time, adding more providers and locations and broadening the types of treatments available to meet the demands from our diverse and expanding population.”
Apparently, UNC Health is going to retain complete ownership of the UNC Fertility practice, with all the physicians and care providers to remain employees of UNC Health. The present patients of UNC Fertility are going to continue to see their already local, dedicated providers.
Moreover, IVI RMA, along with UNC Health, is going to work together to create new opportunities as far as joint research and education programs are concerned. As part of the agreement, IVI RMA is going to partner with UNC Fertility when it comes to UNC Reproductive Endocrinology and the Infertility Fellowship so as to prepare a diverse group of physicians and hence become reproductive endocrinology and infertility service leaders. It is well to be noted that IVI RMA brings in valuable experience due to its present partnership with fellowship programs from Harvard University School of Medicine as well as Thomas Jefferson University.
According to the CEO of IVI RMA North America, Lynn Mason, “It’s an honor to partner with a globally recognized academic medical center like UNC Health and build on their already exceptional clinical foundation and outcomes. We’re excited to work with UNC Fertility as their team continues to grow their presence in North Carolina and the surrounding regions. This partnership reflects our shared dedication to advancing patient care and inspiring future leaders in reproductive endocrinology.”
The Stork Foundation for Infertility received a record 1,076 grant applications in 2026, with data revealing that 85% of applicants have no fertility treatment coverage for the care they are pursuing. Average anticipated next treatment costs stand at 19,149 USD, with 39% having already spent more than 10,000 USD out of pocket.
Future Health, A Global Initiative by Abu Dhabi has launched the Future Health Digital Health Innovation Challenge 2026, inviting global innovators to develop AI, software, and connected technology solutions across fertility, population health, and well-being. Three finalists will share USD 105,000 at GITEX 2026, with selected solutions eligible for incubation and scale.
La Trobe University and GonGlobal have entered a strategic collaboration to develop and validate AI and digital twin technologies for ART and IVF. The partnership will build AI-driven fertility care tools, including cohort matching digital twins and deep-learning models, to predict pregnancy outcomes and support personalised clinical decision-making.
IVI Institute has announced the acquisition of The World Egg and Sperm Bank (TWESB), founded in 2004 and operating from Scottsdale, Arizona. The move expands access to reproductive solutions for patients and clinics across the United States and Australia, combining TWESB’s network of 500+ screened donors with IVI Institute’s global clinical and scientific infrastructure.
Doctors at NHS Lothian in Edinburgh have performed the UK’s first testicular tissue transplant, reimplanting tissue frozen before chemotherapy in a 19-year-old patient with a serious blood disorder. The testicular tissue transplant, only the second reported worldwide, could eventually give thousands of young boys a realistic path to future fatherhood.
Flora Fertility and Clue have announced the Flora Clue fertility partnership, connecting the first individually owned fertility insurance platform with the world’s leading women-led cycle tracking app. FLORA policyholders receive complimentary Clue Plus access, while Clue’s community of over 100 million members gains early exposure to proactive fertility financial planning.
The World Health Organization releases its first comprehensive, evidence-based global guideline for infertility prevention, diagnosis, and treatment. Addressing one in six people of reproductive age worldwide, the guideline emphasizes equity, human rights, and standardized interventions to improve access to fertility care globally.
